Results 111 to 120 of about 2,809,929 (262)
Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy [PDF]
Arrhythmogenic right ventricular cardiomyopathy is an inherited cardiac entity characterized by right ventricular, or biventricular, fibrofatty replacement of myocardium.
Oliva, Antonio
core +1 more source
Background The new designation of arrhythmogenic cardiomyopathy defines a broader spectrum of disease phenotypes, which include right dominant, biventricular, and left dominant variants. We evaluated the relationship between electrocardiographic findings
Manuel De Lazzari +12 more
doaj +1 more source
ABSTRACT Background Pulsed field ablation (PFA) is an emerging non‐thermal ablation modality with proven safety in atrial arrhythmia ablation. However, data on its performance for ventricular arrhythmias (VA) remain limited. Objective To evaluate the feasibility, safety, and efficacy of PFA for complex VA in a multicenter real‐world US registry ...
Narut Prasitlumkum +22 more
wiley +1 more source
Graphical Abstract ABSTRACT Fluoroscopy has traditionally been the mainstay imaging technique for guidance during electrophysiology (EP) ablation procedures. The numerous disadvantages associated with radiation exposure for both operators and patients have created the need for zero‐fluoroscopy (ZF) approaches. Today, electrophysiologists have access to
Dimitrios Kotzadamis +6 more
wiley +1 more source
Cardiovascular imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited cardiomyopathy, usually transmitted with an autosomal dominant trait, characterized by right ventricular myocyte loss with fibrofatty replacement [1] .
Pesarini, Gabriele +4 more
core +1 more source
Mean Platelet Volume in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia [PDF]
Aim: Arrhythmogenic right ventricular cardiomyopathy or dysplasia (ARVC/D) is characterized by the gradual replacement of the right ventricular myocardium with fibrous and adipose tissue and can cause ventricular tachyarrhythmia in young patients.
Nuri Köse +18 more
core +1 more source
Doxorubicin‐induced Cardiotoxicity in Dogs: A Narrative Review
ABSTRACT Doxorubicin, an anthracycline widely used in both human and veterinary oncology, is highly effective against a variety of malignancies in dogs, including lymphomas, sarcomas and carcinomas. Despite its efficacy, doxorubicin exposure can be associated with cardiotoxicity, which may present acutely or chronically, potentially leading to severe ...
Supita Sunpongsri +4 more
wiley +1 more source
The role of the electrophysiologic (EP) study for risk stratification in patients with arrhythmogenic right ventricular cardiomyopathy is controversial.
Lüscher, Thomas F +32 more
core +1 more source
Sport and Arrhythmogenic Right Ventricular Cardiomyopathy [PDF]
Sudden deaths have been reported in sportspersons and have been related to physical activity. It is possible that exercise may be a trigger of potentially lethal arrhythmias in susceptible individuals or may be the factor that converts a defect of ...
Mayosi, B. +3 more
core +1 more source
Sudden cardiac death in patients with nonischemic cardiomyopathy
Sudden cardiac death (SCD) is an important cause of mortality worldwide. Although SCD is most often associated with coronary heart disease, the risk of SCD in patients without ischemic heart disease is well-established.
Brian P. Betensky, Sanjay Dixit
doaj +1 more source

